Found: 15
Select item for more details and to access through your institution.
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2020, v. 55, n. 8, p. 2025, doi. 10.1002/ppul.24815
- By:
- Publication type:
- Article
624. Molecular Characterization of Baseline Enterobacteriaceae and Pseudomonas aeruginosa from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S289, doi. 10.1093/ofid/ofz360.692
- By:
- Publication type:
- Article
2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S760, doi. 10.1093/ofid/ofz360.1905
- By:
- Publication type:
- Article
2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S760, doi. 10.1093/ofid/ofz360.1904
- By:
- Publication type:
- Article
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 466, doi. 10.1002/cpdd.786
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo‐Controlled, Multiple‐Dose Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 4, p. 382, doi. 10.1002/cpdd.429
- By:
- Publication type:
- Article
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 944, doi. 10.1111/bcp.14204
- By:
- Publication type:
- Article
Distinct lineages of T<sub>H</sub>1 cells have differential capacities for memory cell generation in vivo.
- Published in:
- Nature Immunology, 2002, v. 3, n. 9, p. 852, doi. 10.1038/ni832
- By:
- Publication type:
- Article
EFFECT OF ISLATRAVIR ON TOTAL LYMPHOCYTE AND LYMPHOCYTE SUBSET COUNTS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 79
- By:
- Publication type:
- Article
Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 3, p. 352, doi. 10.1002/jcph.2165
- By:
- Publication type:
- Article
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 166, doi. 10.1002/jcph.2149
- By:
- Publication type:
- Article
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia.
- Published in:
- 2020
- By:
- Publication type:
- journal article